Invention Grant
- Patent Title: FGR fusions
-
Application No.: US15326368Application Date: 2015-07-15
-
Publication No.: US10370725B2Publication Date: 2019-08-06
- Inventor: Nicolas Stransky , Ethan G. Cerami
- Applicant: BLUEPRINT MEDICINES CORPORATION
- Applicant Address: US MA Cambridge
- Assignee: Blueprint Medicines Corporation
- Current Assignee: Blueprint Medicines Corporation
- Current Assignee Address: US MA Cambridge
- Agency: Finnegan, Henderson, Farabow Garrett & Dunner, LLP
- International Application: PCT/US2015/040553 WO 20150715
- International Announcement: WO2016/011141 WO 20160121
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C07H21/04 ; C12Q1/6886 ; C12N15/113
Abstract:
FGR (feline Gardner-Rasheed sarcoma viral oncogene homolog) fusions are described herein. Further provided are methods of diagnosing and treating diseases or disorders associated with FGR fusions, such as conditions mediated by FGR aberrant activity, or overexpression.
Public/Granted literature
- US20170211149A1 FGR FUSIONS Public/Granted day:2017-07-27
Information query
